The Safety and Efficacy of Apatinib Treatment in Addition to Concurrent Chemoradiotherapy in Patients with Nonoperative Locally Advanced Esophageal Squamous Cell Carcinoma

BACKGROUND: Esophageal cancer is a common gastrointestinal malignancy in China. We evaluated the efficacy and safety of adding Apatinib to concurrent chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma. MATERIAL/METHODS: In this single-center retrospective study, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Lijun, Kong, Ze, Meng, Qinghong, Wang, Jianlin, Zhou, Mengyun, Yu, Jingping, Jiang, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706142/
https://www.ncbi.nlm.nih.gov/pubmed/33243967
http://dx.doi.org/10.12659/MSM.927221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706142/
https://www.ncbi.nlm.nih.gov/pubmed/33243967
http://dx.doi.org/10.12659/MSM.927221

Ejemplares similares